-
EP4257591
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4257591
| EP4257591 - INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.09.2024 Database last updated on 11.04.2026 | |
| Former | Request for examination was made Status updated on 08.09.2023 | Most recent event Tooltip | 13.09.2024 | Application deemed to be withdrawn | published on 16.10.2024 [2024/42] | Applicant(s) | For all designated states Celgene Quanticel Research, Inc. 9393 Towne Centre Drive, Suite 110 San Diego, CA 92121 / US | [2023/41] | Inventor(s) | 01 /
KANOUNI, Toufike La Jolla, 92037 / US | 02 /
CHEN, Young K. San Marcos, 92078 / US | 03 /
KALDOR, Stephen W. San Diego, 92127 / US | 04 /
STAFFORD, Jeffrey Alan San Diego, 92130 / US | 05 /
VEAL, James Marvin Apex, 27502 / US | [2023/41] | Representative(s) | Richly & Ritschel Patentanwälte PartG mbB Sattlerweg 20 51429 Bergisch Gladbach / DE | [2023/41] | Application number, filing date | 22201620.6 | 10.12.2014 | [2023/41] | Priority number, date | US201361914927P | 11.12.2013 Original published format: US 201361914927 P | [2023/41] | Previously filed application, date | WO2014US69562 | 10.12.2014 | [2023/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP4257591 | Date: | 11.10.2023 | Language: | EN | [2023/41] | Type: | A3 Search report | No.: | EP4257591 | Date: | 22.11.2023 | Language: | EN | [2023/47] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 25.10.2023 | Classification | IPC: | C07D401/14, C07D401/04, C07D403/12, C07D405/14, C07D413/14, C07D401/06, C07D401/12, C07D403/14, C07D413/12, C07D471/04, C07D471/08, C07D471/10, C07D487/04, C07D487/10, C07D491/107, C07D498/08, C07D498/18, C07D519/00, A61P35/00, A61P43/00 | [2023/47] | CPC: |
C07D471/04 (EP,US);
A61P35/00 (EP);
A61P43/00 (EP);
C07D401/04 (EP,US);
C07D401/06 (EP,US);
C07D401/12 (EP,US);
C07D401/14 (EP,US);
C07D403/12 (EP,US);
C07D403/14 (EP,US);
C07D405/14 (EP,US);
C07D413/12 (EP,US);
C07D413/14 (EP,US);
C07D471/08 (EP,US);
C07D471/10 (EP,US);
C07D487/04 (EP,US);
C07D487/10 (EP,US);
C07D491/107 (EP,US);
C07D498/08 (EP,US);
|
| Former IPC [2023/41] | C07D519/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/41] | Title | German: | INHIBITOREN DER LYSIN-SPEZIFISCHEN DEMETHYLASE-1 | [2023/41] | English: | INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 | [2023/41] | French: | INHIBITEUR DE LA DÉMÉTHYLASE-1 SPÉCIFIQUE DE LA LYSINE | [2023/41] | Examination procedure | 14.10.2022 | Examination requested [2023/41] | 23.05.2024 | Application deemed to be withdrawn, date of legal effect [2024/42] | Parent application(s) Tooltip | EP14868829.4 / EP3080100 | Fees paid | Renewal fee | 14.10.2022 | Renewal fee patent year 03 | 14.10.2022 | Renewal fee patent year 04 | 14.10.2022 | Renewal fee patent year 05 | 14.10.2022 | Renewal fee patent year 06 | 14.10.2022 | Renewal fee patent year 07 | 14.10.2022 | Renewal fee patent year 08 | 29.11.2022 | Renewal fee patent year 09 | 15.11.2023 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] WO03082869 (EISAI LONDON RES LAB LIMTED et al.) | [A] WO2011029537 (BAYER SCHERING PHARMA AG et al.) | [A] WO2013175789 (IDEMITSU KOSAN CO et al.) | [A] WO2010012740 (BOEHRINGER INGELHEIM INT et al.) | [A] WO2004048365 (CHIRON CORP et al.) | by applicant | BERGE S.M. ET AL.: "Pharmaceutical Salts", JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 66, 1997, pages 1 - 19, XP002675560, DOI: 10.1002/jps.2600660104 DOI: http://dx.doi.org/10.1002/jps.2600660104 | BUNDGARD, H.: "Design of Prodrugs", 1985, ELSEVIER, pages: 7 - 9 | HIGUCHI, T. ET AL.: "Pro-drugs as Novel Delivery Systems", A.C.S. SYMPOSIUM SERIES, vol. 14 | EDWARD B. ROCHE: "Bioreversible Carriers in Drug Design", 1987, AMERICAN PHARMACEUTICAL ASSOCIATION AND PERGAMON PRESS | S. R. SANDLER ET AL.: "Organic Functional Group Preparations", 1983, JOHN WILEY & SONS, INC. | H. O. HOUSE: "Modern Synthetic Reactions", 1972, W. A. BENJAMIN, INC. | T. L. GILCHRIST: "Advanced Organic Chemistry: Reactions, Mechanisms, and Structure", 1992, WILEY-INTERSCIENCE | FUHRHOP, J.PENZLIN G.: "Organic Synthesis: Concepts, Methods, Starting Materials", 1994, JOHN WILEY & SONS | HOFFMAN, R.V.: "Organic Chemistry, An Intermediate Text", 1996, OXFORD UNIVERSITY PRESS | LAROCK, R. C.: "Industrial Organic Chemicals: Starting Materials and Intermediates: An Ullmann's Encyclopedia", 1999, A GUIDE TO FUNCTIONAL GROUP PREPARATIONS | SOLOMONS, T. W. G.: "Modern Carbonyl Chemistry", 2000, JOHN WILEY & SONS | STOWELL, J.C.: "Intermediate Organic Chemistry", 1993, WILEY-INTERSCIENCE | "Organic Reactions", 1942, JOHN WILEY & SONS | P. H. STAHLC. G. WERMUTH: "Handbook of Pharmaceutical Salts", vol. 73, 2002, VERLAG HELVETICA CHIMICA ACTA | "Remington: The Science and Practice of Pharmacy", 2005, MACK PUB. CO. |